🇺🇸 Minoxidil Topical Foam in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 5
Most-reported reactions
- Alopecia — 1 report (20%)
- Dandruff — 1 report (20%)
- Emotional Distress — 1 report (20%)
- Folliculitis — 1 report (20%)
- Paradoxical Drug Reaction — 1 report (20%)
Other Dermatology approved in United States
Frequently asked questions
Is Minoxidil Topical Foam approved in United States?
Minoxidil Topical Foam does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Minoxidil Topical Foam in United States?
Eurofarma Laboratorios S.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.